TheEdgeResearch
Home / Stocks / ACOPY

a2 Milk Company Limited Unsponsored ADR (ACOPY)

OTC Consumer Defensive Packaged Foods
$4.77 ▲ +0.00%
Market Cap
$3.46B
Sector
Consumer Defensive
Industry
Packaged Foods
Beta
0.28
52-Wk Range
3.8-6.78
CEO
David L. Bortolussi
Country
NZ
Currency
USD

a2 Milk Company Limited Unsponsored ADR operates in the Packaged Foods industry of the Consumer Defensive sector, headquartered in Auckland, AU, NZ. The stock last traded at $4.77, up 0.00% on the session, giving a market capitalisation of $3.46B. On trailing twelve-month figures it carries a trailing P/E of 26.75, a net margin of 11.3%. Its beta of 0.28 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
26.75
Price / Sales
3.01
Price / Book
4.34
EV / EBITDA
16.58
Gross margin
48.1%
Operating margin
14.8%
Net margin
11.3%
Return on equity
Debt / equity
0.02
Current ratio
2.96
Dividend yield
7.6%
Payout ratio
64.4%
Company profile
Exchange
Other OTC
Employees
511
IPO date
2019-05-21
Headquarters
Auckland, AU, NZ
About a2 Milk Company Limited Unsponsored ADR

The a2 Milk Company Limited, together with its subsidiaries, sells A2-type protein type branded milk and related products in Australia, New Zealand, China, rest of Asia, and the United States. The company offers infant milk formula; other nutritional products and milk; manufactures and sells nutritional and ingredients products, as well as provides rent, royalty, and licensing services. It offers its products under the a2 Milk and a2 Platinum brands. The company was formerly known as A2 Corporation Limited and changed its name to The a2 Milk Company Limited in April 2014. The a2 Milk Company Limited was incorporated in 2000 and is based in Auckland, New Zealand.

Comparable companies

a2 Milk Company Limited Unsponsored ADR is most often compared with the following Consumer Defensive names:

BICEYCHFLFCOCSFCUYTYGLAPYKLKBYNCHEYTATYYUNLRFYKLTF
More research on ACOPY
ACOPY technical analysis ACOPY TheEdge Score Compare against peers
Open full interactive analysis & DCF →